UMIN-ICDS History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000049135 |
|---|---|
| Receipt number | R000055909 |
| Scientific Title | Ad-hoc analysis of factors related with efficacies and safeties of mogamulizumab single agent or VCAP/AMP/VECP/mogamulizumab combination therapy for adult T-cell leukemia/lymphoma patients based on clinical trials and research results. |
| Date of disclosure of the study information | 2022/10/17 |
| Last modified on | 2023/10/10 09:37:55 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2022/10/06 09:45:37 | ||
| 2 | Update | 2023/10/10 09:27:26 | Recruitment status |
|
| 3 | Update | 2023/10/10 09:37:55 | Number of participants that the trial has enrolled |
